<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="105841">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01844362</url>
  </required_header>
  <id_info>
    <org_study_id>utx-ld</org_study_id>
    <nct_id>NCT01844362</nct_id>
  </id_info>
  <brief_title>Uterus Transplantation From Live Donor</brief_title>
  <acronym>utx</acronym>
  <official_title>Prospective Case Series of Human Uterus Transplantation From Live Donor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Swedish Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <authority>Sweden: Security committee of EPN Göteborg</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Uterus transplantation, as a possible future treatment for uterine factor infertility, has
      been developed in animal species during the last decade.

      The study protocol includes transplantation of the uterus from a live donor (mother,
      relative, friend) into women with absolute uterine factor infertility (lack of uterus from
      birth or due to life saving hysterectomy).The recipient will be treated by standard
      immunosuppression and transfer of embryos (acquired by IVF before surgery) will be attempted
      when at least 12 months have passed from transplantation. Approval for a case series
      including up to 10 patients has been acquired.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>surviving transplants (12 months)</measure>
    <time_frame>up to 3 years after transplantation</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>pregnancy rate</measure>
    <time_frame>up to 3 years after transplantation</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>live birth rate</measure>
    <time_frame>up to 4 years after transplantation</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Evidence of Uterine Transplantation</condition>
  <condition>Primary Uterine Infertility</condition>
  <arm_group>
    <arm_group_label>Uterine transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo transplantation of the uterus from live donor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>uterine transplantation</intervention_name>
    <description>Transplantation of the uterus from live donor and IVF treatment.</description>
    <arm_group_label>Uterine transplantation</arm_group_label>
    <other_name>uterine transplantation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  less than 39 years

          -  good general health

        Exclusion Criteria:

          -  poor ovarian resaerve or older than 39 years

          -  systemic or psychiatric disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mats Brännström, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Göteborg University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mats Brännström</name>
      <address>
        <city>Göteborg</city>
        <zip>SE-41345</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 1, 2013</lastchanged_date>
  <firstreceived_date>April 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Mats Brännström</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>uterus</keyword>
  <keyword>transplantation</keyword>
  <keyword>infertility</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
